Nanox Imaging is trading 7.13% lower at $0.26 on November 5, 2026, amid a sharply weaker broader market; no fresh company-specific catalyst was identified.
- The latest listed release, on November 2, reported clinical data for its AI solution.
- Investor concerns about technology-sector regulation and risk appetite provide macro context, but do not establish a company-specific cause; available evidence points to broader sentiment.